5-FLUROURACIL (5-FU) TOXICITY AND CHEMOTHERAPEUTIC RESPONSE (DPYD VARIANTS) (SDL10022)

This genetic test identifies DPYD gene variants linked to 5-fluorouracil toxicity. It predicts risk of severe side effects, enabling personalized chemotherapy dosing for safer, more effective cancer treatment.